Attention Deficit Hyperactivity Disorder (ADHD) Industry Market Trends, Size And Growth Analysis H2 2017 To 2022

Overview

Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination and inability to sustain attention on tasks or activities. Treatment includes analeptics.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1773615-attention-deficit-hyperactivity-disorder-adhd-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 5, 10, 8, 15, 6 and 3 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 2 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System). 
- The pipeline guide reviews pipeline therapeutics for Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) therapeutics and enlists all their major and minor projects. 
Table of Contents 

Table of Contents 2 
List of Tables 5 
List of Figures 6 
Introduction 7 
Global Markets Direct Report Coverage 7 
Attention Deficit Hyperactivity Disorder (ADHD) - Overview 8 
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Development 9 
Pipeline Overview 9 
Pipeline by Companies 10 
Pipeline by Universities/Institutes 14 
Products under Development by Companies 15 
Products under Development by Universities/Institutes 18 
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Assessment 19 
Assessment by Target 19 
Assessment by Mechanism of Action 22 
Assessment by Route of Administration 25 
Assessment by Molecule Type 27 
Attention Deficit Hyperactivity Disorder (ADHD) - Companies Involved in Therapeutics Development 29 
4P-Pharma SAS 29 
Aevi Genomic Medicine Inc 29 

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1773615-attention-deficit-hyperactivity-disorder-adhd-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.